Plasma Drug Values of DOACs in Patients Presenting with Gastrointestinal Bleeding: A Prospective Observational Study

Background and Objectives: Anticoagulants are a well-known risk factor for gastrointestinal bleeding (GIB). In recent years, direct oral anticoagulants (DOACs) have taken a leading role in the treatment and prevention of thromboembolic incidents. The aim of this study was to investigate the prevalen...

Descripción completa

Detalles Bibliográficos
Autores principales: Bozic, Dorotea, Alicic, Damir, Martinovic, Dinko, Zaja, Ivan, Bilandzic-Ivisic, Josipa, Sodan, Rosana, Kresic, Branka, Bratanic, Andre, Puljiz, Zeljko, Ardalic, Zarko, Bozic, Josko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456420/
https://www.ncbi.nlm.nih.gov/pubmed/37629757
http://dx.doi.org/10.3390/medicina59081466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456420/
https://www.ncbi.nlm.nih.gov/pubmed/37629757
http://dx.doi.org/10.3390/medicina59081466

Ejemplares similares